Holen Sie sich die Stockscreener-App
1.53
0.65%
-0.01
Vorhandelsmarkt:
1.55
0.02
+1.31%
Schlusskurs vom Vortag:
$1.54
Offen:
$1.55
24-Stunden-Volumen:
130.30K
Relative Volume:
0.52
Marktkapitalisierung:
$8.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-2.0765
EPS:
-0.7368
Netto-Cashflow:
-
1W Leistung:
-1.29%
1M Leistung:
-4.38%
6M Leistung:
-74.40%
1J Leistung:
-90.56%
1-Tages-Spanne:
$1.45
$1.58
1-Wochen-Bereich:
$1.45
$1.6899
52-Wochen-Spanne:
$1.41
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Firmenname
Calidi Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 794-9600
Adresse
4475 Executive Drive, Suite 200, San Diego
Vergleichen Sie CLDI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.53 | 8.24M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-10-09 | Eingeleitet | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
What recovery options are there for Calidi Biotherapeutics Inc.July 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Will Calidi Biotherapeutics Inc. benefit from macro trendsEarnings Trend Report & Growth Focused Stock Reports - newser.com
Can Calidi Biotherapeutics Inc. stock rebound after recent weakness2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi's Project Toward IND - The AI Journal
Calidi Biotherapeutics Inc.’s volatility index tracking explainedRisk Management & Weekly Top Performers Watchlists - newser.com
Using data models to predict Calidi Biotherapeutics Inc. stock movementWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com
What momentum shifts mean for Calidi Biotherapeutics Inc.Market Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
Signal strength of Calidi Biotherapeutics Inc. stock in tech scannersShare Buyback & Daily Profit Focused Screening - newser.com
Multi asset correlation models including Calidi Biotherapeutics Inc.Portfolio Gains Summary & Community Consensus Picks - newser.com
Will Calidi Biotherapeutics Inc. stock outperform small cap peers2025 Price Momentum & AI Enhanced Trading Signals - newser.com
Can Calidi Biotherapeutics Inc. stock beat market expectations this quarterJuly 2025 Weekly Recap & Weekly Momentum Picks - newser.com
Matica Biotechnology inks CDMO deal with Calidi Biotherapeutics to co-develop oncolytic virus therapy - koreabiomed.com
Is Calidi Biotherapeutics Inc. stock supported by strong cash flowsBond Market & Stepwise Entry/Exit Trade Alerts - newser.com
How Calidi Biotherapeutics Inc. stock reacts to stronger dollarEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Calidi Biotherapeutics Inc. stock trendline breakdown2025 Analyst Calls & Weekly High Return Forecasts - newser.com
Key resistance and support levels for Calidi Biotherapeutics Inc.2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
How to manage a losing position in Calidi Biotherapeutics Inc.Buy Signal & Real-Time Volume Surge Alerts - newser.com
What earnings margins imply for Calidi Biotherapeutics Inc. stockWeekly Investment Summary & Real-Time Buy Zone Alerts - newser.com
Will Calidi Biotherapeutics Inc. stock see insider buyingTrade Risk Report & Risk Controlled Daily Plans - newser.com
Full technical analysis of Calidi Biotherapeutics Inc. stockGap Up & High Yield Stock Recommendations - newser.com
Calidi Biotherapeutics Sells Majority Stake in Nova Cell - TipRanks
Calidi Biotherapeutics (CLDI) Stock Trends and Sentiment 2025 - MarketBeat
Calidi announces new data to be presented on CLD-401 at 2025 SITC meeting - TipRanks
CLDICalidi Biotherapeutics Inc Latest Stock News & Market Updates - Stock Titan
Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting - The Manila Times
Calidi (NYSE American: CLDI) to Present CLD-401 at SITC; IND Submission Targeted for 2026 - Stock Titan
Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
Kapitalisierung:
|
Volumen (24h):